The presentation videos and slides for speakers’ lectures are made available, provided that they have granted us permission to do so.
The Chinese HIV Clinical Forum took place as a virtual meeting on 19 November 2022.
Meeting category
Program Language
Chinese and English. Interpretation between will be provided
Meeting type
Virtual Meeting
Organizer
Chinese HIV Clinical Forum 2022
Related Enduring Materials
Enduring Materials
Session 1: Antiretroviral Therapy 2022 - State of ART Plenary Lectures - 14:00
Resistance Considerations in Choice of Regimen
HIV Low-Level Viremia and New Approach to Drug Resistance Surveillance
Pharmacological Considerations in Choice of Regimen
-
Chien-Ching Hung, MD, PhD
International Data Supporting Rapid Start
National Taiwan University Hospital & National Taiwan University Hospital Yunlin Branch / National Taiwan University College of Medicine, Taiwan
Rapid ART Initiation Using BIC/FTC/TAF and TDF+3TC+EFV in HIV Positive Patients in China: A Randomized Controlled Trial
Session 3: Starting and Switching Antiretroviral Therapy in 2022 -
Switching to Newer (Reduced) Drug Regimens in Patients Suppressed on Older Drugs
Clinical Case (focused on starting and switching therapy)
Session 4: Long Acting Antivirals 2022 - Treatment -
Update on Long Acting Therapeutic Options for HIV Treatment
Stopping/Switching Considerations When Using La-ARVs
General
Welcome
The Chinese HIV Clinical Forum took place as a virtual meeting on 19 November 2022.
The HIV CLINICAL FORUM is developed as part of a series of interactive programs that provide independent medical education on emerging topics in HIV. The program features International and regions experts in order to provide HIV clinicians and allied healthcare professionals with updates on the latest developments related to HIV management, providing opportunities for sharing of clinical experience and presenting results from ongoing and completed cohorts/research programs.
This forum meeting provides challenging plenary lectures (in Chinese and English) followed by ample time for Q&A and debate in order to bridge the knowledge gap between experts and the HIV treating community in China. The program includes clinical case presentations to discuss real-life challenges.
The HIV Clinical Forum is a series of interactive programs that provide an independent scientific program on emerging topics in HIV involving experts where HIV clinicians and allied healthcare professionals receive updates on the latest developments related to HIV management, where they can share their clinical experience and present the results from their ongoing and completed cohorts/ research programs.
General Information
COVID-19 Update
Responding to the changing COVID-19 situation, the Chinese HIV Clinical Forum 2022 was held as a virtual meeting.
We are available to answer any questions you may have about your participation at the Chinese HIV Clinical Forum 2022. For more information, please contact Ms. Olivia Zhang at olivia.zhang@amededu.com.
To stay updated on developments in relation to this forum meeting, make sure you are signed up for our newsletter.
We are available to answer any questions you may have about your participation at the Chinese HIV Clinical Forum 2022. For more information, please contact Ms. Olivia Zhang at olivia.zhang@amededu.com.
To stay updated on developments in relation to this forum meeting, make sure you are signed up for our newsletter.
Who Should Attend?
Primary: Medical doctors involved in the management and treatment of people living with HIV in the region
Secondary: Researchers
Tertiary: Healthcare workers, clinical virologists, microbiologists, scientists, pharmacologists, nurses, post-doctoral researchers, students, and other healthcare professionals involved in treating people living with HIV.
Secondary: Researchers
Tertiary: Healthcare workers, clinical virologists, microbiologists, scientists, pharmacologists, nurses, post-doctoral researchers, students, and other healthcare professionals involved in treating people living with HIV.
Meeting Objectives
With the HIV Clinical Forum program, we aim to:
• Build a community of healthcare professionals devoted to providing optimal clinical care for their patients
• Create a platform for interactive information exchange on novel treatment strategies and options
• Translate the latest studies and research achievements into clinical guidance for the optimal management of people living with HIV
• Build a community of healthcare professionals devoted to providing optimal clinical care for their patients
• Create a platform for interactive information exchange on novel treatment strategies and options
• Translate the latest studies and research achievements into clinical guidance for the optimal management of people living with HIV
Learning Objectives
After participating in the HIV Clinical Forum, participants will be able to:
• Understand the scientific rationale and clinical data supporting novel treatment strategies
• Describe the pros and cons of novel treatment strategies and drugs
• Understand how to integrate novel treatment strategies into routine patient care
• Be knowledgeable of the clinical data supporting long-acting injectable regimens
• Identify patients who might most benefit from long-acting injectable regimens
• Gain knowledge on how to optimally integrate injectable drugs into routine clinical care
• Improve their skills in defining and identifying treatment experienced HIV patients
• Stay informed on new drug options for treatment experienced patients
• Understand how best to use new treatment options for highly treatment experienced HIV patients
• Understand the scientific rationale and clinical data supporting novel treatment strategies
• Describe the pros and cons of novel treatment strategies and drugs
• Understand how to integrate novel treatment strategies into routine patient care
• Be knowledgeable of the clinical data supporting long-acting injectable regimens
• Identify patients who might most benefit from long-acting injectable regimens
• Gain knowledge on how to optimally integrate injectable drugs into routine clinical care
• Improve their skills in defining and identifying treatment experienced HIV patients
• Stay informed on new drug options for treatment experienced patients
• Understand how best to use new treatment options for highly treatment experienced HIV patients
Practical Information
We trust that the following information (in alphabetical order) will assist you in organizing your registration and stay at the Chinese HIV Clinical Forum 2022.
Certificate of Attendance
A certificate of attendance will be sent by e-mail after the forum meeting in the following week.
Disclaimer
This forum meeting is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of meeting, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from the meeting. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending this forum meeting.
Languages
The official language of this meeting is Chinese.
Payment and Procedure of Online Registration
Registration is free of charge for all healthcare practitioners. You will get a confirmation of the registration within 1-5 business days. If you did not receive a confirmation, please contact the Organizing Secretariat by e-mail: olivia.zhang@amededu.com.
Committees
The Program Chairs are experts and inspirational leaders in their respective fields. They meet frequently to discuss the scientific program of the meeting, identify interesting topics and candidate speakers, and review all submitted abstracts.
Local Chair
Support
Support
The Chinese HIV Clinical Forum 2022 is supported by an independent educational grant from ViiV Healthcare.
ViiV Healthcare was not involved in the development of content or selection of faculty for this educational activity.
Endorsers
Previous Editions
Previous Editions
- Chinese HIV Clinical Forum Educational Series 2021（https://academicmedicaleducation.com/hiv-clinical-forum/chinese-educational-series-2021）
- Chinese HIV Clinical Forum 2020 (https://academicmedicaleducation.com/hiv-clinical-forum/chinese-2020)
Top-Rated Materials from Previous Editions
HIV/Aids Related Liver Injury and Dyslipidemia - Yongtao Sun, MD, PhD
Media
Top-Rated Materials from Previous Editions
HIV/Aids Related Liver Injury and Dyslipidemia - Yongtao Sun, MD, PhD
